Antidepressant low doses of ketamine and melatonin in combination produce additive neurogenesis in human olfactory neuronal precursors

HIGHLIGHTS

• who: Rosa Estrada-Reyes and collaborators from the Laboratorio Fitofarmacologu00eda, Direcciu00f3n Investigaciones en Neurociencias, Instituto Nacional Ciudad, Mexico University at Buffalo (SUNY), Main Street, Buffalo, NY, USA have published the paper: Antidepressant Low Doses of Ketamine and Melatonin in Combination Produce Additive Neurogenesis in Human Olfactory Neuronal Precursors, in the Journal: Molecules 2022, 5650 of /2022/
• what: The authors show that the KET/MEL increases neurogenesis in a clone derived from human olfactory precursors a translational pre-clinical model for effects in the human CNS. The authors show that the KET/MEL combination at concentrations . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.